GGrantIndex
← Leaderboards

Charles J Rosser

University Of Hawaii At Manoa

Google Scholar ↗PubMed ↗ORCID ↗
$9,823,038
Attributed
$10,426,753
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2016–25
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,426,753 · 6

By mechanism

R01$8,005,544 · 2
UH3$1,208,906 · 1
P30$749,730 · 2
U54$462,573 · 1

Top collaborators

Others in their field

Top investigators on “Evaluation”

Research focus

EvaluationMalignant Neoplasm Of Urinary BladderBiological MarkersBladderProspectiveUrineTumorSamplingMethodologyHematuriaSpecificityCohortValidationMalignant NeoplasmsRecording Of Previous EventsDiagnosticUrinaryBloodPublishingCancer PatientCytologyImmunoassayCystoscopyDiagnosis

Grant awards (26)

MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$666,048
R01 · FY2025 · CA · contact PI
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology$416,215
R01 · FY2025 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$631,484
R01 · FY2024 · CA · contact PI
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology$414,870
R01 · FY2024 · CA · contact PI
APPLICATION OF A MULTIPLEXED IMMUNOASSAY FOR THE DETECTION OF BLADDER CANCER$361,417
UH3 · FY2024 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$651,299
R01 · FY2023 · CA · contact PI
APPLICATION OF A MULTIPLEXED IMMUNOASSAY FOR THE DETECTION OF BLADDER CANCER$389,469
UH3 · FY2023 · CA · contact PI
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology$376,346
R01 · FY2023 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$651,538
R01 · FY2022 · CA · contact PI
Project 3$462,573
U54 · FY2022 · CA · contact PI
APPLICATION OF A MULTIPLEXED IMMUNOASSAY FOR THE DETECTION OF BLADDER CANCER$458,020
UH3 · FY2022 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$726,129
R01 · FY2021 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$652,494
R01 · FY2020 · CA · contact PI
VALIDATION OF A MULTIPLEXED ASSAY FOR BLADDER CANCER DIAGNOSIS$250,500
R01 · FY2020 · CA · contact PI
Clinical Protocol and Data Management$216,284
P30 · FY2020 · CA · contact PI
Protocol Review and Monitoring System$43,954
P30 · FY2020 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$654,552
R01 · FY2019 · CA · contact PI
Clinical Protocol and Data Management$214,828
P30 · FY2019 · CA · contact PI
Protocol Review and Monitoring System$43,658
P30 · FY2019 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$591,360
R01 · FY2018 · CA · contact PI
Clinical Protocol and Data Management$191,989
P30 · FY2018 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$43,671
R01 · FY2018 · CA · contact PI
Protocol Review and Monitoring System$39,017
P30 · FY2018 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$595,314
R01 · FY2017 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$43,671
R01 · FY2017 · CA · contact PI
MULTIPLEXED PROTEIN BIOMARKER-BASED ASSAY FOR THE DETECTION OF BLADDER CANCER$640,053
R01 · FY2016 · CA · contact PI